Based Biosensors market size was valued at US$ 278 million in 2024 and is projected to reach US$ 634 million by 2032, at a CAGR of 12.6% during the forecast period 2025-2032
Report Studies
• The global Piezoelectric Based Biosensors market size was valued at US$ 278 million in 2024 and is projected to reach US$ 634 million by 2032, at a CAGR of 12.6% during the forecast period 2025-2032. While the U.S. currently dominates with an estimated market size of USD 190 million in 2024, China is anticipated to reach USD 230 million by 2032, reflecting strong regional growth dynamics.
• Piezoelectric based biosensors are advanced diagnostic devices that utilize the piezoelectric effect to detect biological molecules with high sensitivity. These sensors convert mechanical energy from molecular binding events into measurable electrical signals, enabling real-time analysis in applications ranging from medical diagnostics to food safety testing. The technology primarily includes two types: quartz crystal microbalance (QCM) and surface acoustic wave (SAW) biosensors, each offering distinct advantages in detection capabilities.
By Type:
• The market is segmented based on type into:
• QCM (Quartz Crystal Microbalance)
• SAW (Surface Acoustic Wave)
• Others
By Application:
• The market is segmented based on application into: • Medical • Food • Industrial • Others
Key Players:
• Biolin Scientific (Addlife) (Sweden)
• AWSensors (Spain)
• Quartz Pro (Sweden)
• INFICON (Switzerland)
• MicroVacuum (Hungary)
• 3T analytik (Germany)
• Gamry Instruments (U.S.)
• Shenzhen Renlu Technology (China)
